Rankings
▼
Calendar
ARCT Q4 2025 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
-65.7% YoY
Gross Profit
$29M
408.3% margin
Operating Income
-$31M
-435.0% margin
Net Income
$47M
650.3% margin
EPS (Diluted)
$-1.05
QoQ Revenue Growth
-58.0%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$271M
Total Liabilities
$57M
Stockholders' Equity
$214M
Cash & Equivalents
$231M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$21M
-65.7%
Gross Profit
$29M
$21M
+39.9%
Operating Income
-$31M
-$33M
+6.3%
Net Income
$47M
-$30M
+256.0%
Revenue Segments
Grant
$4M
57%
Collaboration Revenue
$3M
43%
← FY 2025
All Quarters